Karma Biotechnologies

Biotechnology
Founded in 3/21/17
Torrance, California, United States
http://www.karmabiotech.com/
For Profit

About Karma Biotechnologies

Karma Biotechnologies is a Los Angeles startup dedicated to solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform. General immune suppression is still the standard of care for most autoimmune disease patients; there is a critical unmet need to develop antigen-specific therapies that inhibit only the disease-causing rogue immune cells. To meet this need, Karma is leveraging expertise in immunology and lipid nanoparticle engineering to develop tolerogenic immunotherapies that elicit antigen-specific immune tolerance in vivo.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 4880000 USD
  • Last Funding: 2780000 USD (Seed)
  • Funding Status: Seed

Technology Stack

Karma Biotechnologies actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Torrance, California, United States